PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

PRA International Announces Collaboration with Frontage Laboratories, Inc. - Partnership extends PRA bioanalytical services in North America
PRA International Announces Collaboration with Frontage Laboratories, Inc.


NewswireToday - /newswire/ - Raleigh, NC, United States, 2008/12/03 - Partnership extends PRA bioanalytical services in North America.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


PRA International, a leading Clinical Research Organization (CRO), announced today a collaborative agreement with Frontage Laboratories Inc. This partnership enables PRA Early Development Services' US Clinical Pharmacology Center (PRA EDS US CPC) to now offer a full complement of analytical lab testing services to its existing Phase I -IV clinical trial services in North America.

PRA's state-of-the-art, 80-bed Lenexa clinical facility near Kansas City, Missouri, runs a multitude of Phase I and Phase IIa studies each year, with a particular focus on first in human studies and other complex PK studies. By meaningfully broadening its bioanalytical service portfolio, PRA now offers Pharma and Biotech sponsors and other CROs the ability to align the clinical and laboratory processes, thus saving time by avoiding unnecessary clinical trial delays. It already operates a comparable full-service offering in Europe.

Although PRA conducts clinical trials across a broad spectrum of therapeutic areas, it has a special emphasis in the areas of oncology, central nervous system, allergy/respiratory, cardiovascular disorders and infectious diseases. Frontage Laboratories Inc. is fully compliant with cGMP/GLP regulations and under this new collaboration will offer specialized bioanalytical services via PRA. The new collaboration also offers pharmacokinetic & biostatistical consultancy and data support (including data management, biostatistical and PK/PD analysis and ICH-compliant report writing). Frontage operates a bioanalytical and biomarker research center of excellence in Malvern, PA (near Philadelphia), that houses 17 mass spectrometers and other state-of-the-art instrumentation. Frontage Laboratories' client focus and project management efforts align well with PRA's strategic initiatives.

Dr Wim Tamminga, Senior Director, PRA EDS US CPC commented, "We selected Frontage Laboratories as part of our strategy to offer clients a seamless package consisting of clinical and laboratory services. This service allows us to accelerate Phase I studies and to give sponsors the ability to make better decisions earlier in the drug development process. Frontage is the right partner for this collaboration because they are already a well-established provider of cGMP/GLP compliant testing services. Quality of service, location, and scientific knowledge are what make Frontage Laboratories the best collaborative partner for our bioanalytical services."

Song Li, CEO, Frontage Laboratories, Inc. also noted, "We are delighted that PRA chose Frontage Laboratories to assist in delivering service excellence to all clients and customers across the United States. Our scientific team is recognized industry wide for their expertise in solving complex bioanalytical method development issues quickly and cost effectively, allowing our clients to advance to Phase I studies faster. We look forward to building a collaborative relationship with PRA that not only streamlines project execution but also places a strong emphasis on project management."

With more than 3,300 employees on six continents, PRA delivers reliable service, program-level therapeutic expertise and easy global access to knowledge. PRA offers a broad array of services that encompass the entire spectrum of clinical development, from filing of Investigational New Drug (IND) and similar regulatory applications to product registration and post-marketing studies on a global basis.

About PRA International
PRA International ( is a global Clinical Research Organization providing services through all phases of clinical development. Although we specialize in Oncology, CNS, respiratory/allergy diseases, cardiovascular and infectious diseases, we perform studies in all therapeutic areas. PRA has supported over 2,100 clinical trials through its 30 global offices. PRA's therapeutic expertise, global reach and project experience, combined with local knowledge, enable our project teams to deliver consistent and on time performance for our clients. PRA's Early Development Services (EDS) group provides comprehensive services for Phase I and Phase IIa studies, including: Phase I and IIa clinical research, bioanalytical research and data support.

To learn more about PRA International, please email endpoints[.] or call our Global Headquarters at +1 (919) 7868200.

For more information on PRA bioanalytical services, please contact Peter Ketelaar, Vice President Bioanalytical Laboratory at KetelaarPeter[.] or phone: +31-653-335-810

About Frontage Laboratories Inc.
Based in Malvern, PA, Frontage Laboratories, Inc. ( is a full service, collaborative research and development company that provides bioanalytical and biomarker services, pharmaceutical analysis, formulation development, GMP clinical trial materials (CTM) manufacturing and preclinical study services. Frontage is facilitating the rapid development of NCE's and generic products through its operations in the US and China. Frontage assists its clients with resolving complex product development issues and advancing drug candidates through preclinical and clinical development stages to commercialization.

For more information about Frontage and its services, please contact Ron Connolly, Sr. Vice President Operations at rconnolly[.] or phone +1-610-232-0100.

For further press information please contact Fiona Robinson, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom. P: +44 1477 539539, F: +44 1477 539540, E: fer[.]

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: The Scott Partnership


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+]

# # #

  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

PRA International Announces Collaboration with Frontage Laboratories, Inc.

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Publisher Contact: Fiona Robinson 
+1 (919) 7868200 endpoints[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From The Scott Partnership / Company Profile

Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business


Visit  MagLar, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona

  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (